Idiopathic Short Stature: Diagnostic and Therapeutic Approach

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCANTON, A. P. M.
dc.contributor.authorJORGE, A. A. L.
dc.date.accessioned2023-12-04T19:22:19Z
dc.date.available2023-12-04T19:22:19Z
dc.date.issued2022
dc.description.abstractOur clinical case for discussion is about a short statured boy who was 14.6 years old at his first evaluation. He was born after a 39-week gestation as the third child of a non-consanguineous marriage. His birth weight was 3.250 g (-0.3 SDS), and his birth length was not available. His neuropsychomotor development was normal, his school performance was good, and there were no remarkable findings in his medical history. His father’s height was 174 cm (-0.1 SDS), and his mother’s height was 154 cm (-1.3 SDS), resulting in a target height of 170.6 cm (-0.6 SDS). His father and mother apparently had normal pubertal development, and his mother’s age of menarche was 13 years old. His older brother’s height was not available, but he had a previous history of pubertal spurt after 16 years of age. Likewise, his older sister’s height was also not available, but she had a previous history of menarche at 14. © Springer Nature Switzerland AG 2022.
dc.identifier.citationCanton, A. P. M.; Jorge, A. A. L.. Idiopathic Short Stature: Diagnostic and Therapeutic Approach. In: . Endocrinology and Diabetes: A Problem Oriented Approach: Second Edition: SPRINGER INTERNATIONAL PUBLISHING, 2022. p.163-172.
dc.identifier.doi10.1007/978-3-030-90684-9_16
dc.identifier.isbn978-303090684-9; 978-303090683-2
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/57178
dc.language.isoeng
dc.publisherSPRINGER INTERNATIONAL PUBLISHING
dc.relation.ispartofEndocrinology and Diabetes: A Problem Oriented Approach: Second Edition
dc.rightsrestrictedAccess
dc.rights.holderCopyright SPRINGER INTERNATIONAL PUBLISHING
dc.subjectConstitutional delay of growth and puberty
dc.subjectGrowth
dc.subjectGrowth hormone
dc.subjectGrowth pattern
dc.subjectGrowth-promoting therapies
dc.subjectIdiopathic short stature
dc.titleIdiopathic Short Stature: Diagnostic and Therapeutic Approach
dc.typebookPart
dc.type.categorybook chapter
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcANA PINHEIRO MACHADO CANTON
hcfmusp.contributor.author-fmusphcALEXANDER AUGUSTO DE LIMA JORGE
hcfmusp.description.beginpage163
hcfmusp.description.endpage172
hcfmusp.origemScopus
hcfmusp.origem.scopus2-s2.0-85152808967
hcfmusp.relation.referenceWit J.M., Clayton P.E., Rogol A.D., Savage M.O., Saenger P.H., Cohen P., Idiopathic short stature: Definition, epidemiology and diagnostic evaluation, Growth Hormon IGF Res, 18, pp. 89-110, (2008)
hcfmusp.relation.referenceCooke D.W., DiVall S.A., Radovick S., Normal and aberrant growth in children, Williams textbook of endocrinology, pp. 964-1073, (2016)
hcfmusp.relation.referenceRogol A.D., Hayden G.F., Etiologies and early diagnosis of short stature and growth failure in children and adolescents, J Pediatr, 164, pp. S1-S14, (2014)
hcfmusp.relation.referenceCohen P., Rogol A.D., Deal C.L., Saenger P., Reiter E.O., Ross J.L., Chernausek S.D., Savage M.O., Wit J.M., Consensus statement on the diagnosis and treatment of children with idiopathic short stature:A summary of the growth hormone research society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop, J Clin Endocrinol Metab, 93, 11, pp. 4210-4217, (2008)
hcfmusp.relation.referenceOostdijk W., Grote F.K., Muinck Keizer-Schrama S.M.P.F., Wit J.M., Diagnostic approach in children with short stature, Horm Res, 72, pp. 206-217, (2009)
hcfmusp.relation.referenceMarshall W.A., Tanner J.M., Variations in pattern of pubertal changes in girls, Arch Dis Child, 44, 235, pp. 291-303, (1969)
hcfmusp.relation.referenceMarshall W.A., Tanner J.M., Variations in pattern of pubertal changes in boys, Arch Dis Child, 45, 239, pp. 13-23, (1970)
hcfmusp.relation.referenceMalaquias A.C., Scalco R.C., Fontenele E.G.P., Costalonga E.F., Et al., The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis, Horm Res Paediatr, 80, pp. 449-456, (2013)
hcfmusp.relation.referenceGreulich W.W., Pyle S.I., Radiographic atlas of skeletal development of the hand and wrist, (1959)
hcfmusp.relation.referenceBayley N., Pinneau S.R., Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards, J Pediatr, 40, (1952)
hcfmusp.relation.referenceKant S.G., Grote F., de Ru M.H., Oostdijk W., Zonderland H.M., Breuning M.H., Wit J.M., Radiographic evaluation of children with growth disorders, Horm Res, 68, pp. 310-315, (2007)
hcfmusp.relation.referenceCanton A.P.M., Costa S.S., Rodrigues T.C., Bertola D.R., Et al., Genome-wide screening of copy number variants in children born small for gestational age reveals several candidate genes involved in growth pathways, Eur J Endocrinol, 171, 2, pp. 253-262, (2014)
hcfmusp.relation.referenceDe Bruin C., Dauber A., Insights from exome sequencing for endocrine disorders, Nat Rev Endocrinol, 11, 8, pp. 455-464, (2015)
hcfmusp.relation.referenceSisley S., Trujillo M.V., Khoury J., Backeljauw P., Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children, J Pediatr, 163, pp. 1045-1051, (2013)
hcfmusp.relation.referenceGrimberg A., DiVall S.A., Polychronakos C., Allen D.B., Et al., Guidelines for growth hormone and insulin-like growth factor-1 treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-1 deficiency, Horm Res Paediatr, 86, pp. 361-397, (2016)
hcfmusp.relation.referenceLee P.D., Wilson D.M., Rountree L., Hintz R.L., Rosenfeld R.G., Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing, Pediatr Res, 27, 1, pp. 45-51, (1990)
hcfmusp.relation.referenceElmlinger M.W., Kuhnel W., Weber M.M., Ranke M.B., Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3), Clin Chem Lab Med, 42, 6, pp. 654-664, (2004)
hcfmusp.relation.referenceDauber A., Rosenfeld R.G., Hirschhorn J.N., Genetic evaluation of short stature, J Clin Endocrinol Metab, 99, 9, pp. 3080-3092, (2014)
hcfmusp.relation.referenceJorge A.A.L., Whole exome sequencing in the investigation of growth disorders, including patients with primary IGF-1 deficiency, Horm Res Paediatr, (2017)
hcfmusp.relation.referenceWit J.M., Oostdijk W., Losekoot M., van Duyvenvoorde H.A., Et al., Novel genetic causes of short stature, Eur J Endocrinol, 174, pp. R145-E173, (2016)
hcfmusp.relation.referenceBaron J., Savendahl L., De Luca F., Dauber A., Philip M., Wit J.M., Nilsson O., Short and tall stature: A new paradigm emerges, Nat Rev Endocrinol, 11, 12, pp. 735-746, (2015)
hcfmusp.relation.referenceRanke M.B., Grauer M.I., Kistner K., Blum W.F., Wollmann H.A., Spontaneous adult height in idiopathic short stature, Horm Res, 44, pp. 152-157, (1995)
hcfmusp.relation.referenceGuyda H.J., Four decades of growth hormone therapy for short children: What have we achieved?, J Clin Endocrinol Metab, 84, pp. 4307-4316, (1999)
hcfmusp.relation.referenceDeodati A., Peschiaroli E., Cianfarani S., Review of growth hormone randomized controlled trials in children with idiopathic short stature, Horm Res Paediatr, 76, 3, pp. 40-42, (2011)
hcfmusp.relation.referenceAllen D.B., Growth promotion ethics and the challenge to resist cosmetic endocrinology, Horm Res Paediatr, 87, pp. 145-152, (2017)
hcfmusp.relation.referenceSaggese G., Federico G., Barsanti S., Fiore L., The effect of administering gonadotropin-releasing hormone agonist with recombinant- human growth hormone (GH) on the final height of girls with isolated GH deficiency: Results from a controlled study, J Clin Endocrinol Metab, 86, pp. 1900-1904, (2011)
hcfmusp.relation.referenceYanovski J.A., Rose S.R., Municchi G., Pescovitz O.H., Cassorla F.G., Cutler G.B., Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature, N Engl J Med, 348, pp. 908-917, (2003)
hcfmusp.relation.referenceKamp G.A., Mul D., Waelkens J.J., Jansen M., Et al., A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation, J Clin Endocrinol Metab, 86, pp. 2969-2975, (2001)
hcfmusp.relation.referenceMauras N., Ross J.L., Gagliardi P., Miles Yu Y., Et al., Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic short stature, J Clin Endocrinol Metab, 101, pp. 4984-4993, (2016)
hcfmusp.relation.referenceWickman S., Sipil I., Ankarberg-Lindgren C., Norjavaara E., Dunkel L., A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty, Lancet, 357, 9270, pp. 1743-1748, (2001)
hcfmusp.relation.referenceHero M., Norjavaara E., Dunkel L., Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: A randomized controlled trial, J Clin Endocrinol Metab, 90, 12, pp. 6396-6402, (2005)
hcfmusp.scopus.lastupdate2024-06-16
relation.isAuthorOfPublication791252a6-2c45-4d25-b9f0-6b545f795a4c
relation.isAuthorOfPublication872493f0-3232-484e-a574-207e16fcf202
relation.isAuthorOfPublication.latestForDiscovery791252a6-2c45-4d25-b9f0-6b545f795a4c
Arquivos
Coleções
Livros e Capítulos de Livros - FM/MCM
Livros e Capítulos de Livros - LIM/25
Livros e Capítulos de Livros - LIM/42